Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCerillion Regulatory News (CER)

Share Price Information for Cerillion (CER)

Share Price is delayed by 15 minutes
Get Live Data
1,247.50    5.00 (0.40%)
Bid:
1,235.00
Ask:
1,260.00
Spread: 25.00 (2.024%)
Market Cap: £369.26m
CER Live PriceLast checked at - London Stock Exchange

Intraday Cerillion Share Chart

Trading Update

7 Nov 2006 07:02

Celtic Resources Holdings PLC07 November 2006 Embargoed for 7.05am 7 NOVEMBER 2006 Celtic Resources Holdings Plc ("Celtic" or "the Company") TRADING UPDATE AND ADDITIONAL NOTES ON COMPETENT PERSONS REPORT IN EUREKA MINING PLC CIRCULAR Celtic announced today that the boards of Celtic and Eureka Mining PLC("Eureka") have agreed to the terms of a scheme of arrangement under s.425 ofthe Companies Act whereby Celtic will acquire Eureka (the "Scheme"). The detailsof the Scheme are contained in a separate announcement also released today. Thefull text of the associated Scheme circular to Eureka shareholders will be madeavailable on the Company's website, www.celticresources.com, when the Circularhas been posted to Eureka shareholders. The Circular contains a trading updateby Celtic: CURRENT TRADING Monthly gold production at Suzdal has been increasing and the BIOX(R) plant hascompleted an annual cycle which in Kazakhstan covers climatic temperatures from-40degreesC to +40degreesC. Improvements in plant throughput and gold recoveryare continuing. In addition, consideration is being given to expanding thecapacity of the plant to treat concentrates from other sources, including minesin the region which have sulphide ores similar to Suzdal. Since the interim results, published on 12 September 2006, internal forecastshave been reviewed and due to lower mined grades at Suzdal, Celtic now expectsgold production this year to be around 50,000 ozs. Also, due to treatment oflower grade transitional ores at Zherek, production there should be around12,000 ozs of gold this year. At 62,000 ozs, the combined group production willbe 60% higher than last year. At Zherek, Celtic's preliminary technical and economic studies suggest thatsulphide ore could be mined and trucked to Suzdal. Celtic continues to reviewother mining opportunities, primarily in the FSU. COMPETENT PERSONS REPORT SRK has completed a Competent Persons Report on Celtic's assets for the purposesof the Scheme circular, the full text of which is available in the Schemecircular. This included their resources audit that brought all reserve andresource statements into JORC Code as stated in Celtic's 2005 annual report andaccounts. Kevin Foo, Managing Director commented "The Company is pleased that SRK hasconfirmed a 2 million ozs JORC compliant gold resource. The BIOX(R) plant atSuzdal has demonstrated its robustness over the year and we are now consideringan expansion of the plant from capacity 300,000 t/y to 400,000 t/y. This willallow us to process additional Suzdal ore, Zherek ore and other refractory oresand concentrates in the region, thus taking advantage of the fact that ours isthe first successful application of bacterial oxidation in the FSU. " Notes: Terms in this press release shall have the same meaning as the terms inthe Eureka Scheme circular which will be posted to Eureka shareholders today(and will also be made available on Celtic's website). The Mineral ResourceStatement has been prepared by SRK under the JORC code. For further information please contact: Kevin Foo / Kate Dexter Smith Laurence ReadCeltic Resources Holdings Plc Conduit PRTel: + 44 (0)20 7921 8800 Tel: +44(0)20 7429 6666Investors@celticresources.com laurence@conduitpr.com Frank Moxon / Simon EdwardsEvolution Securities LimitedTel: +44 (0) 20 7071 4300 www.celticresources.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
24th Sep 20078:07 amRNSAcquisition
18th Sep 20077:01 amRNSAnnouncement of Approach
14th Sep 200711:35 amRNSHolding(s) in Company
13th Sep 20073:02 pmRNSResult of AGM
12th Sep 20077:02 amRNSInterim Results
11th Sep 200712:46 pmRNSAcquisition of Option
3rd Sep 20073:16 pmRNSHolding(s) in Company
30th Aug 20079:44 amRNSHolding(s) in Company
29th Aug 20077:00 amRNSAppoints Co-Broker
23rd Aug 20071:11 pmRNSCorrected - Acquisition
23rd Aug 200712:24 pmRNSAcquisition
23rd Aug 200712:23 pmRNSAcquisition
23rd Aug 200712:22 pmRNSAcquisition
17th Aug 200711:54 amRNSAim Rule 26
15th Aug 20075:40 pmRNSHolding(s) in Company
15th Aug 20075:31 pmRNSAcquisition
15th Aug 200711:39 amRNSAGM Statement
14th Aug 20071:22 pmRNSDirector/PDMR Shareholding
14th Aug 20079:07 amRNSSeverstal strategic holding
14th Aug 20077:33 amRNSAcquisition
10th Aug 200712:15 pmRNSHolding(s) in Company
8th Aug 20077:00 amRNSHolding(s) in Company
7th Aug 20075:30 pmRNSAcquisition - SAR 6
31st Jul 200712:43 pmRNSTotal Voting Rights
31st Jul 200712:41 pmRNSHolding(s) in Company
31st Jul 20077:01 amRNSDisposal
26th Jul 200711:13 amRNSAcquisition
19th Jul 20076:00 pmRNSDirector/PDMR Shareholding
19th Jul 20075:43 pmRNSHolding(s) in Company
19th Jul 20077:00 amRNSChange of Adviser
17th Jul 20077:00 amRNSDirectorate Change
5th Jul 20075:29 pmRNSHolding(s) in Company
2nd Jul 20075:17 pmRNSDirector/PDMR Shareholding
29th Jun 200710:03 amRNSPublication of annual r&a
20th Jun 20078:31 amRNSAdditional Listing
19th Jun 20077:01 amRNSFinal Results
12th Jun 20077:00 amRNSFarm out agreement
8th Jun 200712:26 pmRNSHolding(s) in Company
30th May 20077:01 amRNSResource update
29th May 20076:19 pmRNSDirector/PDMR Shareholding
25th May 20079:56 amRNSHolding(s) in Company
24th May 20079:47 amRNSNew Molybdenum Projects
18th May 20073:22 pmRNSHolding(s) in Company
19th Apr 20074:07 pmRNSChange in director's interest
18th Apr 20077:00 amRNSTrading on PLUS
4th Apr 20075:23 pmRNSHolding in Company
20th Mar 20074:39 pmRNSDirector/PDMR Shareholding
5th Mar 20077:01 amRNS2nd joint venture agreemnt
19th Feb 20077:01 amRNSSale of Gekko Equipment
15th Feb 20077:01 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.